Cytokinetics Inc (CYTK)

Stockholders Equity

-$173.49M

Quarterly · Period ending: · USD

CYTK logo

CYTK Stockholders Equity

Latest reported-$173.49M
CYTK Quarterly Shareholders Equity (-$92.03M → -$173.49M)
High-resolution chart · PNG

CYTK stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
-173,487,000
-826,568,000
-659,625,000
-521,123,000
-368,720,000
-266,413,000
-135,372,000
-13,911,000
108,550,000
-396,160,000
-386,323,000
-438,801,000
-333,115,000
-229,020,000
-107,900,000
-15,977,000
111,414,000
116,261,000
243,863,000
249,020,000
16,489,000
67,846,000
113,383,000
149,605,000
-78,080,000
-45,711,000
-10,937,000
-19,869,000
-4,896,000
3,372,000
25,934,000
52,068,000
75,170,000
99,599,000
109,842,000
147,038,000
175,001,000
95,383,000
94,361,000
83,250,000
48,746,000
57,906,000
68,590,000
67,300,000
74,861,000
84,152,000
92,064,000
73,630,000
78,697,000
86,178,000
54,442,000
39,751,000
51,989,000
58,430,000
71,440,000
80,603,000
89,981,000
42,007,000
48,178,000
56,744,000
66,652,000
59,586,000
70,516,000
76,122,000
87,252,000
93,635,000
101,428,000
112,357,000
119,064,000
47,196,000
49,766,000
57,304,000
72,588,000
86,624,000
99,916,000
109,498,000
111,337,000
121,949,000
106,313,000
85,590,000
92,792,000
99,050,000
73,561,000
78,223,000
87,858,000
97,545,000
107,556,000
118,373,000
128,025,000
-97,333,000
-92,031,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.